Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Oct 14, 2024. (Total: 232476Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 6 (of 6 Records)

Query Trace: Colorectal Neoplasms and CYP2C19[original query]
A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
Carcinogenesis 2002 Nov 23 (11): 1839-49.
Sachse Christoph, Smith Gillian, Wilkie Murray J V, Barrett Jennifer H, Waxman Robin, Sullivan Frank, Forman David, Bishop D Timothy, Wolf C Roland,
A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer.
Pharmacogenetics and genomics 2005 Aug 15 (8): 535-46.
Landi Stefano, Gemignani Federica, Moreno Victor, Gioia-Patricola Lydie, Chabrier Amélie, Guino Elisabeth, Navarro Matilde, de Oca Javier, Capellà Gabriel, Canzian Federico,
Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes.
Endocrine-related cancer 2011 Jun 18 (3): 371-84.
Rudolph Anja, Sainz Juan, Hein Rebecca, Hoffmeister Michael, Frank Bernd, Försti Asta, Brenner Hermann, Hemminki Kari, Chang-Claude Jen
Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
Endocrine-related cancer 2011 Apr 18 (2): 265-76.
Sainz J, Rudolph A, Hein R, Hoffmeister M, Buch S, von Schönfels W, Hampe J, Schafmayer C, Völzke H, Frank B, Brenner H, Försti A, Hemminki K, Chang-Claude
Genetic variations in the xenobiotic-metabolizing enzymes CYP1A1, CYP1A2, CYP2C9, CYP2C19 and susceptibility to colorectal cancer among Turkish people.
Genetic testing and molecular biomarkers 2014 Apr 18 (4): 223-8.
Özhan Gül, Mutur Mine, Ercan Gulcin, Alpertunga Buk
Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228).
British journal of cancer 2017 Aug .
Lévi Francis, Karaboué Abdoulaye, Saffroy Raphaël, Desterke Christophe, Boige Valerie, Smith Denis, Hebbar Mohamed, Innominato Pasquale, Taieb Julien, Carvalho Carlos, Guimbaud Rosine, Focan Christian, Bouchahda Mohamed, Adam René, Ducreux Michel, Milano Gérard, Lemoine Antoinet
TOP